Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine - PubMed (original) (raw)

Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine

Jeremiah R McDole et al. Nature. 2012.

Abstract

The intestinal immune system is exposed to a mixture of foreign antigens from diet, commensal flora and potential pathogens. Understanding how pathogen-specific immunity is elicited while avoiding inappropriate responses to the background of innocuous antigens is essential for understanding and treating intestinal infections and inflammatory diseases. The ingestion of protein antigen can induce oral tolerance, which is mediated in part by a subset of intestinal dendritic cells (DCs) that promote the development of regulatory T cells. The lamina propria (LP) underlies the expansive single-cell absorptive villous epithelium and contains a large population of DCs (CD11c(+) CD11b(+) MHCII(+) cells) comprised of two predominant subsets: CD103(+) CX(3)CR1(-) DCs, which promote IgA production, imprint gut homing on lymphocytes and induce the development of regulatory T cells, and CD103(-) CX(3)CR1(+) DCs (with features of macrophages), which promote tumour necrosis factor-α (TNF-α) production, colitis, and the development of T(H)17 T cells. However, the mechanisms by which different intestinal LP-DC subsets capture luminal antigens in vivo remains largely unexplored. Using a minimally disruptive in vivo imaging approach we show that in the steady state, small intestine goblet cells (GCs) function as passages delivering low molecular weight soluble antigens from the intestinal lumen to underlying CD103(+) LP-DCs. The preferential delivery of antigens to DCs with tolerogenic properties implies a key role for this GC function in intestinal immune homeostasis.

© 2012 Macmillan Publishers Limited. All rights reserved

PubMed Disclaimer

Figures

Figure 1

Figure 1. Steady-state trans-epithelial delivery of luminal material in the mouse small intestine

Intestines from CD11cYFP reporter mice injected intraluminally with 10kD dextran (red) imaged with intravital 2P microscopy from the (a) serosal or (b) luminal surfaces. Optical sections at increasing depths (shown in μm) revealed dextran in the lumen (asterisks), the crypts (yellow arrows), on the epithelial surface (unfilled arrow) and columns of dextran that traversed the epithelium (white arrows). Dextran was generally excluded from the LP as identified by CD11cYFP+ LP-DCs (green) below the DAPI stained epithelial nuclei (blue in b). Scale bars = 100μm. (c) Time-lapse recording of LP-DC (green) making repeated contacts with a dextran column (red, white arrow) crossing the epithelium (DAPI stained nuclei, blue). Scale bar=50μm, time stamp=min:sec elapsed time from the start of imaging. (d) Rendered confocal image of a CD11c-YFP+ DC (green) in contact with a dextran filled epithelial cell (red). Panels show orthogonal views; contact is indicated by the white arrow. Scale bar = 5μm. (e) Confocal image of a dextran containing cell (red) bordered by a continuous e-cadherin (blue) positive surface (white arrow). Asterisk indicates the position of an optical section near the cell's center showing intracellular dextran. A CD11cYFP+ DC (green, yellow arrow) positioned near the base of the epithelium. Orthogonal projection (bottom panels); red channel removed (right panels). Scale bar= 5 μm.

Figure 2

Figure 2. GCs are associated with the trans-epithelial passage of luminal material

(a) PAS staining of GCs and (b) dextran columns visualized by 2P microscopy displayed similar morphology and (c) dimensions. (d) Dextran columns were often associated with a nucleus (white arrow). Dextran columns co-localized with GC markers (e) cytokeratin 18 (cyt18, white) and (f) MUC2. (g) Cytokeratin 18 positive cells (white arrows) did not co-localize with the M-cell marker GP2 (yellow arrows). Dextran columns were present in (h) healthy human small intestine and (i) stained positive for cytokeratin 18. Scale bars = 30μm (a, b, and h), 20 μm (d, e, g, and i), and 10μm (f). Error bars = SD.

Figure 3

Figure 3. GAPs deliver soluble antigen to CD103+ LP-DCs in the steady-state

Time-lapse 2P imaging of model antigens (red) (a) dextran and (b) bovine serum albumin (BSA) delivered by GAPs to LP-DCs (CD11cYFP = green). Antigen from GAPs co-localized with LP-DCs (yellow arrow) over time). (c) 2P Imaging of CD11cYFP CX3CR1GFP mice. GAPs delivered antigen preferentially to CD103+ LP-DCs (CD11cYFP+ CX3CR1GFP -; green) over CD103− LP-DCs (CD11cYFP+ CX3CR1GFP+; cyan) LP-DCs. (d) Enumeration of GAPs and GAPs delivering antigen to LP-DC subtypes in CD11cYFP CX3CR1GFP mice in 2P recordings. (e) Flow cytometry of LP cells revealed that CD103+ DCs captured more luminal dextran than CD103− DCs. (f) Cytospins on sorted LP-DCs stained with DAPI (blue) and the GC marker cytokeratin 18 (red). (g) Significantly more CD103+ LP-DCs than CD103− LP-DCs stained cytokeratin 18 positive per high-powered field (p= <0.001). (h) Neither DC population expressed detectable cytokeratin 18 mRNA. Scale bar = 15 μm (a and b), 50μm (c), 25μm (f). Data in (g) taken from 9 or more high powered fields (representing >150 cells) Data in (h) performed in triplicate and is representative of two experiments. Error bars = SEM.

Figure 4

Figure 4. GAPs are a source of luminal antigen for CD103+ LP-DCs in the steady-state

(a) 2P time-lapse images of a LP-DC (CD11cYFP+, green) acquiring fluorescent Ova (white arrow) from a GAP (red) in the intestinal epithelium (DAPI stained nuclei, blue). Scale bar = 15 μm; time stamp = min:sec of elapsed time. (b) LP-DC antigen presentation capacity in mice given luminal Ova or PBS assessed on day 3 by (b and c) CFDA dilution and (d) by counting the number of T cells after co-culture with LP-DCs. (c) CD103− LP-DCs induced comparable T cell proliferation to CD103+ LP-DCs when exogenous antigen was added to the in vitro cultures (blue histogram), PBS controls (red histograms). (e and f) 2P imaging of GAPs and LP-DCs in carbamylcholine (CCh) treated mice. Carbamylcholine (CCh) increased the number of GAPs and the co-localization of 10kD dextran (red) with LP-DCs (green). (f, Inset), LP-DCs capturing dextran (white arrowheads). (g) Luminal antigen presentation by LP-DCs following CCh administration as compared to controls given luminal Ova. (h) GF mice had increased GAPs (red = 10kD dextran; DAPI, blue). (i) Luminal antigen presentation by LP-DCs from GF mice was significantly enhanced compared to LP-DCs from SPF housed mice. CD103+ LP-DCs presented luminal antigen significantly better than CD103− LP-DCs from GF mice. (j) 2P imaging of intestines in Math1fl/flVilCre mice (M1KO). M1KO mice lacked GAPs (red, 10 kD dextran) in the epithelium (blue, DAPI). (k) Luminal antigen presentation by LP-DCs from M1KO mice was undetectable. Scale bar in a = 20μm and f = 40μm. ns = not significant. * = p<0.05, ** = p<0.01, *** = p<0.001. Error bars = SEM. Data in d, g, and k are representative of three or more independent experiments, data in (i) was representative of two independent experiments. In (e), n = 15 or more images obtained from 3 animals for each condition.

Comment in

Similar articles

Cited by

References

    1. Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev. 241:241–259. doi:10.1111/j.1600-065×.2011.01017.x. - PMC - PubMed
    1. Jaensson E, et al. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med. 2008;205:2139–2149. doi:10.1084/jem.20080414. - PMC - PubMed
    1. Johansson-Lindbom B. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. J Exp Med. 2005;202:1063–1073. doi:10.1084/jem.20051100. - PMC - PubMed
    1. Uematsu S, et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol. 2008;9:769–776. doi:10.1038/ni.1622. - PubMed
    1. Varol C, et al. Intestinal Lamina Propria Dendritic Cell Subsets Have Different Origin and Functions. Immunity. 2009;31:502–512. doi:10.1016/j.immuni.2009.06.025. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources